Charles Schwab’s Stemline Therapeutics, Inc. STML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-294,035
Closed -$1.42M 3404
2020
Q1
$1.42M Buy
294,035
+6,191
+2% +$30K ﹤0.01% 2399
2019
Q4
$3.06M Buy
287,844
+12,563
+5% +$134K ﹤0.01% 2266
2019
Q3
$2.87M Buy
275,281
+181,200
+193% +$1.89M ﹤0.01% 2247
2019
Q2
$1.44M Sell
94,081
-596
-0.6% -$9.14K ﹤0.01% 2468
2019
Q1
$1.22M Buy
94,677
+30,386
+47% +$391K ﹤0.01% 2495
2018
Q4
$611K Sell
64,291
-264
-0.4% -$2.51K ﹤0.01% 2698
2018
Q3
$1.07M Buy
64,555
+5,530
+9% +$91.8K ﹤0.01% 2606
2018
Q2
$948K Buy
59,025
+4,700
+9% +$75.5K ﹤0.01% 2603
2018
Q1
$832K Buy
54,325
+7,300
+16% +$112K ﹤0.01% 2576
2017
Q4
$734K Buy
47,025
+6,825
+17% +$107K ﹤0.01% 2616
2017
Q3
$447K Hold
40,200
﹤0.01% 2747
2017
Q2
$370K Hold
40,200
﹤0.01% 2787
2017
Q1
$344K Buy
40,200
+14,200
+55% +$122K ﹤0.01% 2779
2016
Q4
$279K Hold
26,000
﹤0.01% 2868
2016
Q3
$282K Hold
26,000
﹤0.01% 2809
2016
Q2
$177K Sell
26,000
-2,000
-7% -$13.6K ﹤0.01% 2978
2016
Q1
$131K Hold
28,000
﹤0.01% 2958
2015
Q4
$177K Hold
28,000
﹤0.01% 2983
2015
Q3
$248K Hold
28,000
﹤0.01% 2896
2015
Q2
$330K Hold
28,000
﹤0.01% 2836
2015
Q1
$406K Buy
28,000
+15,000
+115% +$218K ﹤0.01% 2712
2014
Q4
$222K Hold
13,000
﹤0.01% 2957
2014
Q3
$162K Hold
13,000
﹤0.01% 2996
2014
Q2
$191K Hold
13,000
﹤0.01% 3006
2014
Q1
$265K Hold
13,000
﹤0.01% 2853
2013
Q4
$255K Hold
13,000
﹤0.01% 2876
2013
Q3
$613K Hold
13,000
﹤0.01% 2465
2013
Q2
$326K Buy
+13,000
New +$326K ﹤0.01% 2700